ATC Group: G04CA02 Tamsulosin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of G04CA02 in the ATC hierarchy

Level Code Title
1 G Genito urinary system and sex hormones
2 G04 Urologicals
3 G04C Drugs used in benign prostatic hypertrophy
4 G04CA Alpha-adrenoreceptor antagonists
5 G04CA02 Tamsulosin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code Route Amount Notes
ORAL Oral 0.4 mg

Active ingredients in G04CA02

Active Ingredient

Tamsulosin binds selectively and competitively to post-synaptic α1-adrenoreceptors, prevailingly their subtypes designated α1A and α1D. Thus relaxation of smooth muscles of the prostate and urethra is achieved, which leads to a reduction of tonus and an improvement of the urinary flow.

Related product monographs

Document Type Information Source  
 BENIPROSIN Capsule MPI, Generic Health Products Regulatory Authority (ZA)
 CONTIFLO XL Prolonged release capsule MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 FLOMAX Capsule MPI, US: SPL/PLR FDA, National Drug Code (US)
 FLOMAXTRA Film-coated prolonged-release tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 OMNIC Modified release capsule, hard MPI, EU: SmPC Web Search
 OMSULA Prolonged-release capsule, hard MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 TANYZ Hard modified-release capsule MPI, EU: SmPC Health Products Regulatory Authority (IE)

United States medicines

Medicines classified under this ATC code globally

Albania (AL)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Italy (IT)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.